Cleveland BioLabs (cbli) announces offering by selling shareholders
In a Form S-3 late last week, Cleveland BioLabs announced that it will offer 11,014,424 shares of its common stock by selling shareholders.
Boston Scientific Corporation today announced that it has completed the sale of the controlling interests in its auditory business and drug pump development program to former principals and shareholders of Advanced Bionics.